4074
CapSure Sense
VENTRICULAR PLACEMENT
Device Survival Probability
4074_VEN_SURV
Loading...
| 1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13 yr | 14 yr | at 174.0 mo | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % |  |
99.4 | 99.3 | 99.2 | 99.2 | 99.2 | 99.2 | 99.2 | 99.2 | 99.2 | 98.7 | 98.7 | 98.0 | 98.0 | 97.0 | 97.0 | ||||||
| # | 1017 | 848 | 699 | 593 | 462 | 377 | 305 | 249 | 206 | 165 | 149 | 138 | 114 | 77 | 64 |
Product Surveillance Registry Results
| Number of Leads Enrolled in Study | 1185 |
|---|---|
| Cumulative Months of Follow-Up | 72167 |
| Number of Leads Active in Study | 283 |
11
Qualifying Complications
| Conductor Fracture | 1 |
|---|---|
| Failure to Capture | 3 |
| Impedance Out of Range | 2 |
| Insulation (not further defined) | 2 |
| Lead Dislodgement | 2 |
| Other | 1 |
ATRIAL PLACEMENT
Device Survival Probability
4074_ATR_SURV
Loading...
| 1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13 yr | 14 yr | at 174.0 mo | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | |
99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | 99.1 | ||||||
| # | 214 | 205 | 198 | 183 | 167 | 158 | 148 | 136 | 127 | 117 | 107 | 103 | 95 | 64 | 58 |
Product Surveillance Registry Results
| Number of Leads Enrolled in Study | 227 |
|---|---|
| Cumulative Months of Follow-Up | 26500 |
| Number of Leads Active in Study | 94 |
2
Qualifying Complications
| Failure to Capture | 0 |
|---|---|
| Failure to Sense | 1 |
| Impedance Out of Range | 0 |
| Lead Dislodgement | 1 |
| Other | 0 |
Customer Communications For This Model
- There are no communications for this model.
US Acute Lead Observations
| Cardiac Perforation | 29 |
|---|---|
| Conductor Fracture | 2 |
| Extra Cardiac Stimulation | 3 |
| Failure to Capture | 145 |
| Failure to Sense | 9 |
| Impedance Out of Range | 4 |
| Lead Dislodgement | 181 |
| Oversensing | 7 |
Distribution Data
| US Market Release | 2002-06-23 |
|---|---|
| CE Approval Date | 2002-02-01 |
| Registered USA Implants | 146013 |
| Estimated Active USA Implants | 66665 |
| US Market Release | 2002-06-23 |
|---|---|
| CE Approval Date | 2002-02-01 |
| Estimated WW Distribution | 983840 |
USA Returned Product Analysis
| Conductor Fracture | 12 |
|---|---|
| Insulation Breach | 50 |
| Crimp/Weld/Bond | 0 |
| Other | 0 |
WW Returned Product Analysis
| Conductor Fracture | 19 |
|---|---|
| Insulation Breach | 53 |
| Crimp/Weld/Bond | 0 |
| Other | 5 |
Product Characteristics
| Lead Type | Pacing |
|---|---|
| Type and/or Fixation | Tines |
| Lead Function | Pacing/Sensing |
| Lead Placement | Transvenous |
| Lead Tip Location | Right Ventricle |
| Pace/Sense Polarity | Bipolar |
| Serial Number Prefix | BBD |
|---|---|
| Lead Body Diameter | 5.3 FR |
| Insulation | Polyurethane (outer) Silicone (inner) |
| Pace/Sense Connector Style | IS-1 BI |
| High Voltage Connector | n/a |
| Steroid | Yes |
Data as of October 11, 2021